These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16904281)

  • 1. Comparison of the recovery spread in analytical development and routine quality control--based on the ICH quality guideline Q2B.
    Schepers U; El Deeb S; Ermer J; Wätzig H
    J Pharm Biomed Anal; 2007 Jan; 43(2):708-10. PubMed ID: 16904281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of analytical methods involved in dissolution assays: acceptance limits and decision methodologies.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chim Acta; 2012 Nov; 751():44-51. PubMed ID: 23084050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pressurized solvent extraction in quality control of Chinese herb].
    Li P; Li SP; Fu CM; Kan KW; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):723-6. PubMed ID: 15506276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Technical implications on the quality standard of new drugs].
    Uchiyama M
    Eisei Shikenjo Hokoku; 1995; (113):135-6. PubMed ID: 8717247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical considerations in setting product specifications.
    Dong X; Tsong Y; Shen M
    J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of analytical procedures: a panel of strategies selected for risk management, with emphasis on an integrated equivalence-based comparative testing approach.
    Agut C; Caron A; Giordano C; Hoffman D; Ségalini A
    J Pharm Biomed Anal; 2011 Sep; 56(2):293-303. PubMed ID: 21700410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to evaluate regression models during validation of bioanalytical assays.
    Singtoroj T; Tarning J; Annerberg A; Ashton M; Bergqvist Y; White NJ; Lindegardh N; Day NP
    J Pharm Biomed Anal; 2006 Apr; 41(1):219-27. PubMed ID: 16332425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using tolerance intervals for assessment of pharmaceutical quality.
    Dong X; Tsong Y; Shen M; Zhong J
    J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G
    J Pharm Biomed Anal; 2008 Jan; 46(1):104-12. PubMed ID: 17961955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.
    Kean T; Miller JH; Skellern GG; Snodin D
    Pharmeur Sci Notes; 2006 Dec; 2006(2):23-33. PubMed ID: 17691211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the probability of passing the USP dissolution test.
    Wang H
    J Biopharm Stat; 2007; 17(3):407-13. PubMed ID: 17479390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and analysis of method equivalence studies.
    Borman PJ; Chatfield MJ; Damjanov I; Jackson P
    Anal Chem; 2009 Dec; 81(24):9849-57. PubMed ID: 19925005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observations on the specifics in the quality of drugs].
    Setnikar I
    Boll Chim Farm; 1968 Mar; 107(3):158-67. PubMed ID: 5730323
    [No Abstract]   [Full Text] [Related]  

  • 16. A Generalized Pivotal Quantity Approach to Analytical Method Validation Based on Total Error.
    Yang H; Zhang J
    PDA J Pharm Sci Technol; 2015; 69(6):725-35. PubMed ID: 26659103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
    Tsong Y; Yang H
    J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
    [No Abstract]   [Full Text] [Related]  

  • 18. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminatory power of the different requirements for uniformity of dosage units in the European pharmacopoeia.
    Limberg J; Savsek M
    Pharmeur Sci Notes; 2006 Dec; 2006(2):45-8. PubMed ID: 17691214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.